Agile Therapeutics Inc (AGRX.OQ)
18 Apr 2018
* AGILE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
* Perceptive Advisors LLC Reports A 9.9 Pct Passive Stake In Agile Therapeutics Inc As Of Dec 22, 2017 - SEC Filing Source text: (http://bit.ly/2FlgqN8) Further company coverage:
Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug developer's shares down about 50 percent.
Dec 22 Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve the company's contraceptive patch, citing deficiencies related to its adhesion test methods.
* AGILE THERAPEUTICS, INC. RECEIVES A COMPLETE RESPONSE LETTER FROM THE FDA FOR TWIRLA® (AG200-15) FOR THE PREVENTION OF PREGNANCY
* Agile therapeutics reports third quarter 2017 financial results